CAMBRIDGE, Mass., Jan. 12 -- Solace Pharmaceuticals, a private biotechnology company discovering and developing innovative treatments for pain, announced the initiation of a proof-of-concept clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results